J Comput Chem July 2020 PMID 32449536

HCVpred: A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors.

Aijaz Ahmad Malik, Chuleeporn Phanus-Umporn, Nalini Schaduangrat, Watshara Shoombuatong, Chartchalerm Isarankura-Na-Ayudhya, Chanin Nantasenamat

Mentions

11
Peak: 6 in May 2020
across 3 sources since May 2020

Extended reach

116,681
potential audience

Total likes

655

Video views

47,933

Mentions per month

May 2020 – Dec 2020

Where it's discussed

  • X / Twitter8 posts
  • YouTube2 videos
  • News1 articles

AI synopsis

What people are saying

The group’s discourse indicates a neutral to positive stance, with mentions of the paper being 'finally out' and referencing its utility as a web server for predicting HCV inhibitors, emphasizing its potential in drug design, though without deep technical analysis or critical evaluation. The tone is appreciative but somewhat reserved, favoring acknowledgment over in-depth discussion.

AgreementNeither agree nor disagree

The discussions show general acknowledgment of the publication's significance but lack detailed critique or strong opinions.

InterestModerate interest

Participants express moderate interest, mainly highlighting the publication's availability and potential applications.

EngagementModerate engagement

Responses are somewhat engaged, with some appreciation for collaborative efforts and mentions of related topics like drug discovery.

ImpactModerate impact

While the discussions recognize the relevance, they do not emphasize transformative or wide-reaching impacts heavily.

Abstract in brief

  • Hepatitis C virus (HCV) affects 170 million people globally, leading to significant liver disease and high mortality rates, with NS5B being a critical target for developing antiviral therapies.
  • A classification structure-activity relationship (CSAR) model was created to identify effective compounds against HCV, demonstrating robust predictive performance through various statistical measures and high modelability.
  • Key descriptors for NS5B inhibition were identified, and the predictive model is available as the HCVpred web server, enabling users to evaluate compound activity against HCV NS5B to aid in drug design.

Top posts

Most liked on X and Bluesky
Chanin Nantasenamat
@thedataprof · X

Build a Machine Learning Model for Computational Drug Discovery from Scratch (#Weka Tutorial #4)

Nov 9, 2020 · 8 likes · 2 shares · 29,727 followers View post →
M@£!K
@Immunobiotics · X

Finally our paper is out ....special thanks to @thedataprof and other co-authors HCVpred : A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors https://t.co/AphMvIuVp1

May 31, 2020 · 3 likes · 3 shares · 145 followers View post →
Arbovirus News
@ArboNews · X

HCVpred: A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors. https://t.co/o9j6pPDOWJ

May 26, 2020 · 1 like · 5,061 followers View post →
Chanin Nantasenamat
@thedataprof · X

RT @Immunobiotics: Finally our paper is out ....special thanks to @thedataprof and other co-authors HCVpred : A web server for predicting…

May 31, 2020 · 3 shares · 29,727 followers View post →
CompChemBio Bot
@CompChemBioBot · X

RT @thedataprof: Build a Machine Learning Model for Computational Drug Discovery from Scratch (#Weka Tutorial #4)

Nov 9, 2020 · 2 shares · 2,741 followers View post →
Paperbirds_Oncology
@PaperbirdsO · X

New article: HCVpred: A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors. https://t.co/pm7DPDqInJ #livercancer #oncology https://t.co/u2l5cpfmRy

May 26, 2020 · 889 followers View post →

All mentions

CompChemBio Bot
@CompChemBioBot · X

RT @thedataprof: Build a Machine Learning Model for Computational Drug Discovery from Scratch (#Weka Tutorial #4)

Nov 9, 2020 · 2 shares · 2,741 followers View post →
Chanin Nantasenamat
@thedataprof · X

Build a Machine Learning Model for Computational Drug Discovery from Scratch (#Weka Tutorial #4)

Nov 9, 2020 · 8 likes · 2 shares · 29,727 followers View post →
Chanin Nantasenamat
@chanin_nanta · X

RT @Immunobiotics: Finally our paper is out ....special thanks to @thedataprof and other co-authors HCVpred : A web server for predicting…

May 31, 2020 · 3 shares · 272 followers View post →
Chanin Nantasenamat
@thedataprof · X

RT @Immunobiotics: Finally our paper is out ....special thanks to @thedataprof and other co-authors HCVpred : A web server for predicting…

May 31, 2020 · 3 shares · 29,727 followers View post →
M@£!K
@Immunobiotics · X

RT @Immunobiotics: Finally our paper is out ....special thanks to @thedataprof and other co-authors HCVpred : A web server for predicting…

May 31, 2020 · 3 shares · 145 followers View post →
M@£!K
@Immunobiotics · X

Finally our paper is out ....special thanks to @thedataprof and other co-authors HCVpred : A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors https://t.co/AphMvIuVp1

May 31, 2020 · 3 likes · 3 shares · 145 followers View post →
Arbovirus News
@ArboNews · X

HCVpred: A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors. https://t.co/o9j6pPDOWJ

May 26, 2020 · 1 like · 5,061 followers View post →
Paperbirds_Oncology
@PaperbirdsO · X

New article: HCVpred: A web server for predicting the bioactivity of hepatitis C virus NS5B inhibitors. https://t.co/pm7DPDqInJ #livercancer #oncology https://t.co/u2l5cpfmRy

May 26, 2020 · 889 followers View post →
Investigation on low-performance tuned-regressor of inhibitory ...
News

2020, doi: 10.1002/jcc.26223. Investigation on low-performance tuned-regressor of inhibitory concentration … (Daniel Febrian Sengkey). 3012 ISSN: 2252 ...

Dec 29, 2025 View →